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Review Article
Introduction
The oral cavity consists of a range of structures, including the 
teeth, tongue, gingiva, and hard and soft palettes, with the latter be-
ing composed of stratified squamous cells.1 A healthy oral environ-
ment is characterized by a rapid cellular turnover rate, with the soft 
and hard palettes averaging between 14 and 24 days, respectively.2 
One of the main purposes of the rapid turnover of the oral epithe-
lium is as a defense mechanism, reducing the rate of pathogenic 
microbial colonization by removing the region they bind to.2 It 
also serves multiple additional functions, such as a physical barrier 
and immune defense to potential pathogens and toxins and in pro-
viding an environment that is optimal for the established healthy 
microbiome.1
The turnover of the mucosal cells in the oral cavity is dependent 
on a balance between cell differentiation and desquamation, which 
primarily acts as a pathogen defense mechanism.3 However, this 
can become unbalanced and lead to the development of several 
conditions, including hyperplasia and dysplasia, and a reduced 
rate of proliferation, which can lead to the development of ulcera-
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Background and objectives: A healthy oral environment features a rapid turnover rate of epithelium cells capable 
of regeneration and repair, with the oral epithelium contributing as a physical barrier and immune defense. How-
ever, the oral cavity can be subjected to unique damage, such as ulcerations. Honey is reported as a therapeutic 
agent for wound healing, due to its antioxidant, antibacterial and anti-inflammatory properties.
Methods: A systematic review was performed following the PRISMA 2015 Guidelines, to assess the efficacy and safety 
of the therapeutic use of honey in the oral cavity. Four electronic databases were searched (PubMed, Cochrane Library, 
Scopus, and Web of Science) for randomized controlled trials examining the effect of honey on oral cavity conditions.
Results: In total, 2,832 records were identified, and after applying exclusion criteria, 13 studies were included. 
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tal wounds (n = 1), and recurrent aphthous stomatitis (n = 1), all of which are ulcerations with different patholo-
gies. In the majority of studies (12/13), honey reduced the severity and/or duration of the condition compared 
with control groups (all p<0.05). However, a group treated with Manuka honey (n = 1) experienced adverse effects 
and considerable participant attrition.
Conclusions: Honey is an effective treatment for a range of oral ulcerative conditions. Future research should 
focus on compositional analysis of honeys to determine those with optimal beneficial properties, and whether 
Manuka honey is safe to use in the oral cavity.
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tions.2 Additionally, the oral mucosa is subject to masticatory and 
abrasive damage, with this oral epithelium disruption having the 
possibility of leading to the development of oral diseases1; some 
of these common oral conditions include dental caries, denture 
wounds, and ulcerations.4
The treatment of adverse health conditions in the oral cavity 
is focused on therapies that simultaneously eradicate pathogenic 
microbial growth, stimulate the wound healing process, and reduce 
the sensation of pain. One possible treatment option that fulfils 
these criteria is honey, which has been demonstrated to be effective 
in the treatment of a range of wounds, such as burns and ulcers.5 
These potentially beneficial effects can be attributed to its antioxi-
dant, antibacterial, and anti-inflammatory properties.5–7
The composition of honey, in particular the exact proportions 
of each of its constituents, is dependent on the floral source of the 
pollen used to produce the honey.8 Overall, honey is a mixture of 
several different categories of compounds, including polyphenols, 
ascorbic acid, carotenoids, organic acids, enzymes and other pro-
teins,9 all of which contribute to honey being a viable nutritional 
source of antioxidants.10 Honey displays strong antioxidant activity 
and has the ability to reduce the effects of oxidative reactions, which 
produce free radicals and reactive oxygen species (ROS).8 In addi-
tion, honey is also reported to exhibit strong antibacterial effects, 
which can be attributed to its physicochemical properties, such as 
high osmolarity (due to high sugar levels)5 and relatively low pH11 
due to the presence of several organic acids. Additionally, activation 
of glucose oxidase during the dilution of honey causes the produc-
tion of hydrogen peroxide from glucose metabolism, providing an 
undesirable environment for growth and proliferation of bacterial 
cells12 and potentially mediating the wound healing process.13
The concomitant effects of the antioxidant and antibacterial 
properties of honey also contribute to its anti-inflammatory ef-
fects of reducing excessive inflammation, possibly resulting in a 
wound-healing effect.6 As the presence of ROS has been deter-
mined to lead to the production of inflammation,14 the antioxidant 
activity of honey can also contribute to a reduction of an excessive 
inflammatory response.7 Moreover, honey’s capability to prevent 
the development of bacterial infections (through providing an en-
vironment that cannot support bacterial growth and proliferation) 
can further assist with the inhibition of inflammation.5 Further-
more, the application of honey to a wound has been demonstrated 
to stimulate the production and release of pro-inflammatory cy-
tokines that assist in the wound healing process, such as interleu-
kin-1 and tumor necrosis factor-alpha.5 The topical application of 
honey to various injured tissues has also been shown to stimulate 
wound repair through the stimulation of growth of epithelial cells, 
reduction of edema, and wound debridement.6,7
It is well established that an individual’s oral health impacts their 
quality of life.4,15,16 Poor oral health is shown to affect physical 
and psychological wellbeing through condition-related reductions 
in functionality, including the inability to consume adequate nutri-
tion and communicate, undesirable effects on physical appearance, 
in addition to causing pain.15 These conditions, particularly those 
related to the soft and hard palette such as ulcerations, have been 
reported as treated using various types of honey in several different 
clinical populations.17–19 These collective data suggest honey as a 
reliable food product, being both financially affordable and readily 
available, that could be used in the treatment of inflammatory and 
microbial damage of the epithelial lining of the oral cavity. There-
fore, this systematic review aimed to assess the efficacy of honey 
as a therapeutic agent used for the treatment of epithelial damage 
due to the inflammatory and microbial response in the oral cavity. 
Additionally, this review will aim to evaluate the safety of honey 
in different clinical populations.
Methods
This systematic review has been completed in accordance with 
the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) 201520 Guidelines and was registered in the 
International Prospective Register of Systematic Reviews (PROS-
PERO Number: CRD42019128480). The systematic review was 
completed following the Population, Intervention, Comparator, 
Outcomes and Setting (PICOS) approach as follows:
Population: Human populations with an existing oral health 
condition, or at risk of developing an oral health condition.
Intervention: Randomized controlled trials utilizing topically-
applied undiluted honey from any floral source as a treatment or 
preventative agent without the concurrent use of other treatments. 
Only trials containing sample sizes over 12 participants were in-
cluded; however, there was no time limit placed on study duration.
Comparator: Human comparators being treated with a placebo, 
control or routine standard oral care.
Outcomes: Effects of honey treatment on severity of oral health 
conditions, improvements in healing time, and any adverse effects 
to participants caused by the use of honey during and following the 
intervention protocol.
Setting: Any.
Search strategy
The following four electronic databases were searched; Scopus, Pub-
Med, Cochrane Library and Web of Science, for manuscripts pub-
lished since journal inception until June 2019. Furthermore, searches 
were also conducted to identify any new publications prior to sub-
mission of this manuscript (end of October 2019). The searches were 
limited to studies that were conducted on humans, were randomized 
controlled trials, and were published in peer-reviewed journals in the 
English language. The reference lists of included articles were also 
searched to locate any additional articles relating to the topic. The 
search terminology used included “honey*” and “oral”, “mouth”, “in-
traoral”, “cavity”, “bucc*”, “tooth”, “orthodont*”, “saliv*”, and “dis-
ease”, “condition”, “lesion”, “wound”, “carie*”, “plaque”, “ulcer”, 
“bacter*”, “micro”, “count”, with the terms AND and OR between 
every term.
Selection criteria
Studies were included if they were original research, randomized 
controlled trials published in English and in peer-reviewed jour-
nals. Articles were only considered if they utilized undiluted 
honey without any other interventions as a treatment against a 
pre-existing condition of the mouth or as a preventative agent in a 
group more susceptible to developing an oral condition. Further-
more, articles were required to have a control or placebo group 
as a comparator. Any articles that did not meet these criteria were 
excluded from this review. There were no time limitations posed 
on the duration of the studies, as oral conditions have different 
durations and pathological severities. For the purpose of this sys-
tematic review, a condition of the mouth was defined as a symp-
tomatic problem unique to the oral cavity, such as ulcers or dental 
wounds.
Data extraction
All articles identified in the initial electronic search were imported 
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into an EndNote library (vX8.2; Clarivate Analytics, USA) and 
duplicates removed. We excluded articles that did not investigate 
honey or oral health conditions. Following this, articles were ex-
cluded based on study design, and only if pure undiluted honey 
was utilized in the absence of any other treatments, with the excep-
tion of patient-required analgesics.
Two authors (MH and JK) independently screened each of the 
articles based on the selection criteria. The titles were screened 
to determine relevance, followed by screening of abstracts to de-
termine studies suitable for full-text analysis. Any disagreements 
regarding the selection criteria were resolved through discussion 
until consensus was reached or in consultation with a third author 
(NN). At this stage, the reference lists of the articles considered for 
full-text review were searched for additional articles. The extrac-
tion of relevant data was completed by two authors (MH and JK) 
working independently in predesigned tables including the infor-
mation on author name, year of publication, condition assessed, 
honey application protocol, control or placebo, number of partici-
pants, and outcomes.
Assessment of bias
The risk of bias was independently assessed according to the 
Cochrane Collaboration’s Tool for Assessing Bias, which utilizes 
the domains of selection bias through random sequence genera-
tion and allocation concealment, performance bias through blind-
ing of participants and personnel, detection bias through blinding 
of outcome assessment; attrition bias through the addressing of 
any incomplete data, reporting bias through selective reporting, 
and any other sources of bias.21 The risk of bias was assessed 
independently by two authors (MH and JK), with a third author 
(NN) introduced in the case of any disagreements, where appro-
priate.
Data analysis
Due to the broad inclusion criteria used for this review to include 
a number of ulcerative lesions, which includes a variety of popula-
tion groups and intervention protocols, this review consists of con-
siderable heterogeneity. As such, a meta-analysis was not deemed 
appropriate.
Results
Study selection
The initial search of the electronic databases (Fig. 120) resulted 
in 2,838 articles, with the secondary searches identifying 1 
article. Following removal of articles due to duplicates (n = 
1,181), study design (n = 115), absence of honey investigation 
(n = 1,416) and absence of oral health intervention (n = 80), 
46 studies were subjected to full text-analysis. Articles were 
further excluded due to use of diluted honey with or without 
the use of additional therapies (n = 14), unsuitable oral health 
conditions (n = 12) and study design (n = 8), with 13 studies 
fitting the inclusion criteria.22–34 An article investigating the use 
of honey to assist in the recovery of dental extraction surgery35 
was considered but it was determined that since this wound is 
due to surgery, and not a condition unique to the oral cavity, this 
article was excluded.
Study characteristics
The characteristics of the included studies are presented in Table 
1.22–34 The total number of participants recruited in the included 
studies was 634, with sample sizes ranging from 20 to 106 par-
ticipants. Of these, 11 studies investigated oral mucositis (OM) 
in 579 cancer patients,22–32 1 investigated 35 participants with 
denture-induced ulcers,33 and 1 investigated 20 participants with 
recurrent aphthous stomatitis (RAS).34 Although the selection 
criteria of this review was designed to include a broad range of 
oral health conditions, the intervention was common across stud-
ies, with pure, undiluted honey being applied topically to affected 
areas in the mouths of patients in the treatment groups. The type 
of honey and their floral sources used in the included studies was 
largely unspecified26,28,30,33,34; however, two studies stated that the 
honey was sourced from a commercial supermarket.23,27 Five of 
the studies identified the local flora that was used in the production 
of the honey used,22,24,29,31,32 and one study specified their use of 
Manuka honey.25
In the included articles, participants were instructed to main-
tain good oral hygiene (n = 6)22,24–26,31,32 or prescribed the use 
of antibacterial, antifungal or analgesic solutions (n = 3).22,23,32 
However, this was not specified in six studies.27–30,33,34 For trials 
investigating OM (n = 11), the studies investigated head and neck 
cancer patients in adult populations24–32 and pediatric patients re-
ceiving treatment for a range of cancers, including leukemia.22,23 
Participants with radiotherapy-induced OM were included in six 
studies,24,25,27–29,31 with 1 study having investigated chemother-
apy-induced OM22 and 4 having determined the effect of honey 
on concurrent chemo-radiotherapy-induced OM.23,26,30,32 These 
studies utilized routine oral care,23,24,30,32 saline rinses of differ-
ent concentration ranges (0.9%,27 0.09%,31 and unspecified26), 
water,28 and a variety of anesthetic and analgesic solutions (7.5% 
benzocaine gel,22 15% benzydamine hydrochloride,27 lignocaine 
gel29) serving as controls, while only one study utilized a placebo 
gel25 and another developed their own mixture.22
Interventions
In a study by Biswal et al.,24 patients receiving radiotherapy for 
head and neck cancer were provided with 20 mL of honey to smear 
on the inside of their mouths, and instructed to swallow it slowly 
in order to coat both the oral and pharyngeal mucosa, with ap-
plication occurring 15 min before and after they received radio-
therapy and 6 h after receiving radiotherapy, for the duration of 
the treatment cycle. This study design was also replicated by other 
studies included in this review,27,29–32 with Jayalekshmi et al.28 
and Howlader et al.26 with slight modifications, namely use of 15 
mL of honey28 and consumption of additional honey to potentially 
contribute to serum antioxidant levels.26
The remaining studies investigating OM utilized study designs 
similar to those above, topically coating the oral cavity with hon-
ey; however, the amounts of honey used and timing of applica-
tion were different. In trials by Al Jaouni et al.23 and Hawley et 
al.25 durations were similar of treatments used to Biswal et al.24 
and participants were followed throughout the duration of their 
oncology treatments. In addition, Hawley et al.25 maintained the 
intervention for 7 days following final radiotherapy treatment, with 
all studies applying the honey intervention four times daily. The 
volumes of honey and subsequent saline rinse were not specified 
by Al Jaouni et al.23 but Hawley et al.25 specified the prescription 
of 5 mL of applied honey followed by a fluoride rinse. Abdulrhman 
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et al.22 included participants with established OM using undiluted 
honey (0.5 g/kg) and having two control groups (receiving a cus-
tom-made mixture (placebo) or an analgesic control). All groups 
applied their mixtures three times daily for 10 days or until healing 
of ulceration.
The study by Ceylan et al.33 investigated the use of honey in 
the treatment of traumatic ulcers that were caused by newly fit-
ted dentures in 35 healthy, previously edentulous participants. Of 
these, 25 participants were provided with honey and instructed to 
smear directly onto the ulcers three times daily for 3 days follow-
ing denture fitting. The control group (n = 10) were provided with 
a saline rinse to use via the same protocol as the treatment group. 
The ulcer areas were measured in all participants using planimetry 
on the first and third day following initial denture fitting.
The study by Halim et al.34 investigated the effectiveness of 
honey in the treatment of RAS in healthy adults. Following an ini-
tial assessment, participants in the treatment group (n = 10) were 
given honey and control groups (n = 10) were given salicylate gel, 
a standard prescribed treatment for RAS, to apply to their ulcers 3 
times daily for 5 days. Ulcer size was determined using calipers, 
and a visual analog score was used to assess pain before and after 
the intervention.
Study results
The majority of studies investigating the use of honey in the treat-
ment of OM in an oncology population were successful in alleviat-
ing negative symptoms, including reducing the severity or duration 
of the condition (all p<0.05) (Table 1).22–24,26–29,31,32 In these stud-
Fig. 1. Search strategy and article selection process according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
Guidelines.20 
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ies, OM was assessed using a grading scale, with Grade 1 repre-
senting less severe cases and Grade 4 being the most severe. In 
these studies, the onset of OM was delayed in the honey-treatment 
group compared to the control group, and fewer participants in the 
honey group of each study developed higher gradings of the condi-
tion. One OM study did not report any significant changes from 
pre- to post-treatment nor any difference between the two groups 
(treatment and control); however, there was a self-reported ob-
served difference in the OM.30 All of these studies utilized standard 
honey from no particular floral source, with no adverse reactions 
reported throughout the duration of the honey intervention, except-
ing one study31 that reported the exclusion of participants who re-
ported a stinging sensation, though the number of exclusions and 
effect on the study was not disclosed. A single study by Hawley et 
al.25 utilized Manuka honey and reported no significant difference 
in the severity or duration of OM between the honey and placebo 
groups (p = 0.77); however, this study experienced considerable 
dropout rate (57% in the honey group, 52% in the placebo group), 
mainly attributed to the sensation of nausea caused by the applica-
tion of the honey.
It was determined that honey significantly (p value unreported) 
relieved the symptoms of the denture-induced ulcers earlier than in 
the control group, and (as assessed by a visual analogue score) re-
duced pain, with no adverse effects.33 Finally, while no participants 
with RAS reported adverse effects, no significant difference was 
found between the honey group and control group of a currently 
utilized treatment for ulcer size (p = 0.879) and pain (p = 0.514); 
however, self-reported improvements were observed.34
Risk of bias in included studies
The risk of bias was assessed according to the Cochrane Risk of 
Bias Tool and is outlined in Table 2.22–34 The risk of selection 
bias through allocation concealment was high for the included 
studies, which was due to placebo products being utilized by 2/13 
studies.22,25 Additionally, Jayalekshmi et al.28 reported the use of 
similar bottles for both their treatment and control groups, result-
ing in a low risk of selection bias. Similarly, the performance 
bias was high or unclear, which was attributed to the common 
utilization of controls rather than a placebo. The detection bias 
for the included studies was relatively unclear but there was an 
overall low risk of attrition and reporting bias (Table 2). No other 
bias was detected.
Discussion
Effectiveness of honey
The primary aim of this review was to determine the effectiveness 
of topically-applied honey in the treatment of a range of oral health 
conditions. Of the 13 studies included in this review, 10 reported 
statistically significant reductions in the severity of the oral health 
condition compared to a control group, including 9 studies inves-
tigating OM22–24,26–29,31,32 and 1 investigating denture wounds.33 
While one study did not report any significance30 and another re-
ported no significant difference in the improvement of RAS,34 the 
oral condition was improved in both studies, demonstrating that 
honey was just as effective as the standard prescribed treatments 
for these conditions. Only one study, by Hawley et al.,25 did not 
report any improvements in oral condition.
It has been proposed that honey possesses wound healing abili-S
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ties due to its antioxidant and antibacterial properties,5–7 which in-
cludes the ability to heal ulcerations. All conditions included in this 
review culminated in the development of an oral ulcer, which had 
formed due to the loss and necrosis of epithelial tissue and result-
ing in breaks in the skin or mucous membrane36; each condition 
formed due to different pathologies. Oral mucositis is a condition 
that develops as a toxicity during oncology treatments (chemother-
apy and radiotherapy) and is characterized by inflammation, ery-
thema, microbial colonization, and ulceration.37 Similarly, RAS is 
a condition of unknown cause that affects the lining of the mouth, 
causing erythema, burning and ulceration,34 and denture-induced 
ulcers are caused by the introduction of ill-fitting dentures causing 
abrasive damage to the lining of the mouth, resulting in ulcerative 
lesions.33
The antibacterial and antioxidant properties of honey contribute 
to honey’s wound-healing abilities. In the case of OM, the ini-
tiation phase is characterized by the production of ROS,37 which 
could potentially cause further damage to the affected areas. A 
study investigating participants with RAS determined that those 
with the condition had significantly lower salivary antioxidant 
levels compared to healthy controls,38 demonstrating that the ul-
cerations potentially produced ROS, causing a reduction in the 
antioxidant compounds present in the mouth. This highlights a 
possible mechanism for the effectiveness of honey as a treatment 
for the ulcerations discussed in this review. Potentially, the pres-
ence of the antioxidant compounds provided by the topically-ap-
plied honey can reduce the effects of ROS activity during the de-
velopment of ulcerations. Furthermore, the consumption of honey 
increases total systemic plasma antioxidant levels, and swallow-
ing of the topically-applied honey may contribute to longer lasting 
antioxidant effects,10 further contributing to the wound healing 
process.
Adverse effects
The secondary aim of this systematic review was to determine any 
adverse effects during the topically-applied honey interventions. 
Only one of the included studies reported an adverse effect due to 
the honey intervention.25 Namely, Hawley et al.25 reported con-
siderable dropouts due to nausea, which could be attributed to the 
treatments being associated with radiotherapy; however, it was 
reported that the Manuka honey that was used worsened nausea 
symptoms and encouraged a retching motion. A study by Bardy 
et al.39 also used Manuka honey and reported a low compliance 
rate due to the honey being difficult to use, along with an undesir-
able taste and texture. A study by Parsons et al.40 initially had to 
be discontinued due to the Manuka honey not being well-tolerat-
ed by participants, and in that study all participants withdrew due 
to a perceived stinging pain and nausea following application. In-
terestingly, Abdulrhman et al.22 reported no adverse side effects 
in the honey intervention arm of their study, which used honey 
from a different floral source to Manuka honey; however, in their 
comparative group using their own formulation, discomfort was 
reported, which was proposed to be due to the addition of propo-
lis. The studies investigating denture wounds33 and RAS34 did 
not report any adverse effects. This further supports evidence that 
the application of honey to the inside of the oral cavity is effec-
tive in reducing the pathogenic bacteria that cause dental caries, 
and has a positive effect on plaque levels and gingivitis.17,41,42 
These findings demonstrate that the use of honey in future studies 
is safe for the dental health of participants. It was also proposed 
that similar trials comparing two intervention groups of Manuka 
and conventional honey should be completed18; however, given Ta
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the evidence of the adverse effects of Manuka honey, this may 
not be feasible.
Issues with use and development of placebo
The majority of the studies included in this review (n = 12) uti-
lized a control or ‘standard’ prescribed care in the place of a pla-
cebo. Due to the nature and progression of oral health conditions 
included in this review, particularly OM in oncology patients, it 
would be unethical to provide no treatment to the control group, 
resulting in most studies in this review receiving standard care or 
a commonly-used treatment. This is also partially reflected by the 
reported bias (Table 2), where many studies were graded as having 
a “high risk” of selection and performance bias, with the exception 
of the study by Jayalekshmi et al.28 who utilized similar packaging 
for their honey treatment and control.
If a placebo were to be used in future studies to assess the effec-
tiveness of honey as a topical treatment, it would be best practice 
to use products which share certain physicochemical properties 
with honey to support undetectability by participants, such as its 
properties of osmolarity and acidity.31 The use of such a placebo 
could have confounding effects, as the physicochemical properties 
of honey, including its osmolarity, contribute to honeys wound-
healing abilities.19 One such example is brought forth by the study 
by Bardy et al.,39 which had been excluded (during full-text re-
view) from our review due to not having used undiluted honey. 
In that study, golden syrup which has a similar appearance and 
texture to honey, was assigned as a placebo alongside a Manuka 
honey treatment for OM. While there was no significant differ-
ence observed in the severity or duration of the OM between the 
treatment and control groups (p > 0.05), the pathogenic bacteria 
present in both groups was consistent with baseline throughout the 
study period, demonstrating that both honey and the placebo con-
trolled the bacterial growth. This further supports the notion of the 
importance of osmolarity action (shared by the honey and golden 
syrup) on the antibacterial activity of honey.
The only study in this review that utilized a placebo was com-
pleted by Hawley et al.,25 where the product was developed to look 
like honey. Similar to the study by Bardy et al.,39 this study did not 
result in a significant reduction in the severity or duration of the 
OM experienced by participants; however, this could be attributed 
to the possible non-suitability of Manuka honey for this type of 
treatment, rather than the activity of the placebo. Additionally, a 
study by Abdulrhman et al.22 developed a honey-containing prod-
uct, which they assessed as a treatment for OM alongside a treat-
ment group that received pure, undiluted honey, in addition to the 
use of a standard care control (Table 1).
It is evident that the utilization of a placebo in studies of this 
nature is not practical, and so further care should be taken in future 
studies to ensure that both participants and researchers are blinded 
to the allocation of honey or control. This could potentially be 
achieved through disclosing that the intervention is designed to 
improve the oral health condition, while not specifying that honey 
is the treatment.
Compositional properties of used honeys
It is well established that several honey properties can contribute 
to its wound healing effects, including a combination of antioxi-
dant, physicochemical and antimicrobial properties. However, the 
optimal levels of compounds or categories of compounds, includ-
ing their interaction with each other, that can contribute to the ob-
served beneficial health effects of honey, are largely unexplored. 
Four of the included studies, all investigating OM, completed in 
vitro analysis of the potential wound healing properties, including 
pH,22,24,31,32 moisture content,22,24,31,32 phytochemical profile,24,32 
and microbiological analysis.24,31 However, none of the studies 
utilized these results in their discussion on the effectiveness of 
honey as a treatment. A trial of this nature should be completed to 
determine the individual in vitro wound healing properties of dif-
ferent types of honey, so that recommendations can be offered to 
participants experiencing these oral health conditions about what 
type of honey should be used to provide optimal benefits. Due to 
the overall lack of analysis of the honey utilized in these trials, it 
is difficult to draw conclusions about the best type/s of honey and 
the properties that are most appropriate for use in the treatment of 
these oral conditions.
Limitations
The inclusion criteria for this review evaluated only articles that 
utilized pure, undiluted honey as a treatment, as the concurrent 
utilization of other compounds or medications has the possibility 
to contribute to any potential beneficial effect provided by just the 
honey in isolation. As a result, studies that utilized honey and no 
other treatments were included, though the use of standard care was 
allowed. It would be unethical to request that patients discontinue 
their normal oral care routines for the duration of an intervention, 
due to the potential impact on their dental health. Additionally, the 
conditions investigated in this review can cause considerable pain, 
which could lead to the requirement of the additional analgesics. 
This may provide a reduction in the effectiveness of the honey; 
however, the use of honey in isolation to routine oral care in in-
terventions such as the ones included in this review is impractical.
Future research proposals
The adverse effects caused by Manuka honey highlighted in this re-
view should be taken into consideration of future research for oral 
health conditions. Manuka honey contains relatively high levels of 
methylglyoxal (MGO), which has been identified to be unique to 
this type of honey and directly contributes to Manuka honey’s an-
tibacterial abilities.43,44 This compound also occurs in humans as a 
by-product to metabolic processes, such as glycolysis45; however, 
it has been shown to exhibit potentially toxic side effects, includ-
ing the ability to modify DNA and other macromolecules.46 Addi-
tionally, in healthy human cells, the tripeptide glutathione (GSH) is 
capable of suppressing the activity of MGO47; however, once a cell 
becomes damaged, such as during the oral conditions discussed in 
this review, there is a reduction in the expression of GSH.48 This 
can result in further damage, with GSH depletion leading to MGO 
accumulation.49 This is depicted in Figure 2, where, in a healthy 
oral cavity, GSH is able to suppress the activity of MGO, thereby 
preventing any cellular modifications. Although, when Manuka 
honey is applied to the damaged oral cavity, the reduced levels of 
GSH allow the levels of MGO to increase, and to potentially cause 
further cellular damage.
As previously discussed, one study included in this review 
reported considerable adverse effects following the topical appli-
cation of Manuka honey.25 Studies of similar interventions also 
reported adverse effects,39,40 which could potentially be due to the 
proposed interactions between MGO and reduced levels of GSH. 
These adverse reactions were not observed in studies utilizing hon-
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ey from other floral sources, with the topical application of honey 
to a damaged oral cavity being demonstrated to result in improve-
ments to the oral condition (Fig. 2).
While Manuka honeys have demonstrated substantial potential 
wound healing abilities in vitro and in vivo,11,44,50 there is currently 
a lack of relevant clinical trials utilizing this product for wound 
healing treatments. Due to its compositional properties, it should 
be considered that Manuka honey be utilized in clinical trials for 
site-specific topical application in wound sites other than the oral 
cavity, such as a laceration or burn on the skin to test for effective-
ness and tolerability. Similarly, further trials in the treatment of 
oral conditions or investigating alternative application sites could 
be completed to determine optimal levels of MGO that can be tol-
erated.
Conclusion
The use of honey as a therapeutic treatment of oral conditions has 
been identified to be effective in reducing the duration and sever-
ity of conditions in comparison to standard treatments and con-
trols. Specifically, it has been demonstrated that honey is effective 
against a range of oral ulcers with multiple pathologies and, in 
particular, in the treatment of oral mucositis. Any adverse reactions 
Fig. 2. Effect of honey on the oral cavity. (a) GSH present in the healthy oral cavity suppresses the activity of MGO from Manuka honey. (b) The use of honey 
does not cause adverse effects in a healthy oral cavity, and is effective in treating a damaged oral cavity. (c) Reduced levels of GSH in the damaged oral cav-
ity do not suppress the activity of MGO from Manuka honey, with the MGO potentially causing further damage, and Manuka honey not being an effective 
treatment. GSH, tripeptide glutathione; MGO, methylglyoxal.
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that were reported throughout the duration of the included studies 
could be attributed to the type of honey used and were not due to 
the type of oral health condition, demonstrating that the topical 
application of honey, other than Manuka honey, is relatively safe 
for use across a range of oral health conditions. The use of honey 
for the treatment of oral mucositis should be considered for fur-
ther research; however, control over honey composition should be 
taken into consideration, particularly phytochemical composition. 
The use of Manuka honey in the treatment of oral cavity conditions 
should be carefully considered before use, with future investiga-
tions required to determine its safety.
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